Can I read Farletuzumab Safety in Ovarian Cancer Study on EtoBox?

Farletuzumab Safety in Ovarian Cancer Study by dilapidates is a document available to read on EtoBox.

What is Farletuzumab Safety in Ovarian Cancer Study about?

This Phase 1b safety study evaluated the combination of farletuzumab, carboplatin, and pegylated liposomal doxorubicin in patients with platinum-sensitive epithelial ovarian cancer. The treatment was generally well tolerated, with adverse events similar to those of carboplatin/PLD alone, and no severe farletuzumab-related adverse events reported. The study found promising responses, with one complete response and ten partial responses among the participants.

Author

dilapidates

Language

EN